The Cutaneous Connection

In this episode of The Cutaneous Connection, Dermatology Times revisits a recent video episode of the Derm Dispatch show where host Renata Block, DMSc, MMS, PA-C, sits down with Zachary Rubin, MD — allergist, pediatrician, and New York Times bestselling author of All About Allergies — to explore the intersection of dermatology and allergy. Together, they tackle one of the most persistent myths in practice: that food elimination can treat atopic dermatitis. Dr. Rubin breaks down the difference between IgE-mediated allergic reactions and the complex inflammatory nature of eczema, explains the atopic march, and discusses how understanding the gut-lung-skin axis can empower patients to take charge of their care. The conversation also covers the latest treatment advances — from JAK inhibitors to novel biologics — and touches on indolent systemic mastocytosis and the truth about so-called hypoallergenic dogs. A must-listen for any clinician treating allergic and inflammatory skin disease.For more content, visit https://www.dermatologytimes.com/

Join Dermatology Times for a conversation with Liza O'Dowd, MD, vice president of immunodermatology and respiratory disease areas at Johnson & Johnson, recorded at the 2026 AAD Annual Meeting. Dr. O'Dowd discusses one-year efficacy and safety data for icotrokinra (Icotyde), the newly approved once-daily oral peptide IL-23 receptor antagonist for moderate to severe plaque psoriasis in adults and adolescents 12 and older. At 52 weeks, approximately 50% of adult patients achieved total skin clearance, rising to 60% in adolescents enrolled in the LEAD study. Adverse event rates through one year remained within 1.1% of placebo, with no mandatory tuberculosis pre-screening required. Dr. O'Dowd also addresses icotrokinra's anticipated role as a first-line systemic therapy and offers practical reassurance for clinicians considering this novel agent for their patients.For more content from Dermatology Times, visit https://www.dermatologytimes.com/

In this episode, board-certified dermatologist of US Dermatology Partners, Daniel Walker, MD, FAAD, shares emerging insights into the expanding role of GLP-1 receptor agonists beyond their primary use in diabetes and weight loss, highlighting their promising—yet still investigational—impact on inflammatory skin diseases such as psoriasis and HS. 

In this conversation, identical twin practitioners—dermatologist Amy Spizuoco, DO, FAOCD, and dentist Stacy Spizuoco, DDS,—discuss how dentistry and dermatology intersect in shared patients, from oral lesions and skin conditions to cosmetic collaborations that brighten and rejuvenate smiles “by the skin of your teeth.” 

In this episode, we sat down with Doris Day, MD, a board-certified dermatologist in New York City, who's 25-year long career focuses on longevity aesthetics. She discussed the most common cutaneous concerns among menopausal women, insights from Galderma’s recent menopause survey, and how dermatologists can thoughtfully incorporate conversations about hormonal health into aesthetic consultations. 

In the latest installment of Dermatology Times' video series, the Derm Dispatch, host Renata Block, DMSc, MMS, PA-C, sits down with indolent systemic mastocytosis patient advocate Suki Tipp to examine the clinical, emotional, and financial toll of delayed diagnosis—and the critical role dermatology clinicians can play in recognizing this rare disease earlier.Now a vocal advocate, Tipp encourages dermatology clinicians to consider systemic mastocytosis in patients presenting with recurrent urticaria, flushing, unexplained brown macules, and systemic symptoms.

In a recent Derm Dispatch episode produced by Dermatology Times, Renata Block, DMSc, MMS, PA-C, spoke with Isabelle Thibau, MPH, director of the EczemaWise app from the National Eczema Association (NEA), about the clinical and patient care implications of this digital tool.

Itisha S. Jefferson, a medical student, patient advocate, and one of the co-founders of the Scarring Alopecia Foundation's medical student program, shares the inspiring advocacy journey and team effort behind the approval of ICD-10 codes for scarring alopecias.

We recently caught up with Peter Lio, MD, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, at the 2024 Society for Pediatric Dermatology Annual Meeting. Lio presented a session on changing the disease course in pediatric atopic dermatitis, alongside Amy Paller, MD. We'll dive into the highlights of their talk, the role of disease progression, and the exciting pipeline ahead.

In today’s episode, Drs Vikash Oza, MD, and James Treat, MD, delve into the topic, “Does Food Trigger Eczema?” Oza, an associate professor of dermatology and pediatrics and the director of pediatric dermatology at NYU in New York City, and Treat, a professor of clinical pediatrics and dermatology at the Perelman School of Medicine and an affiliate of the Children’s Hospital of Philadelphia, participated in 1 of 3 “Great Debates in Peds Derm” at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. The duo shared insights from their debate and pearls for clinicians related to allergy and eczema. 

In today’s episode, Albert Yan, MD, FAAP, FAAD, research director at the Children's Hospital of Philadelphia, professor at the Perelman School of Medicine, and executive at Inner Archways LLC, discusses pearls and insights from his lecture presented at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. Yan spoke on artificial intelligence and ChatGPT and the balance of positive yet harmful potential of AI chatbots in medicine. 

James Song, MD, FAAD, chief medical officer and director of clinical research at Frontier Dermatology in Seattle, Washington, delves into the complexities and advancements in treating atopic dermatitis (AD). Song highlights the challenges of transitioning patients from topical to systemic therapies, emphasizing the need for timely conversations and patient comfort. He discusses the efficacy and rapid response of oral JAK inhibitors compared to biologics, while addressing safety concerns and the necessity for blood monitoring. Song also explores patient-specific factors in treatment choices, the importance of systemic therapy for moderate to severe cases, and the promise of emerging biologics targeting IL-31 and OX40 pathways. This episode is a comprehensive guide for dermatology clinicians navigating the evolving landscape of AD treatments. 

In today’s episode, Nanette Silverberg reviews the key highlights from her vitiligo sessions at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, also known this year as RAVE. Dr. Silverberg is the chief of pediatric dermatology for the Mount Sinai Health System and site director of pediatric and adolescent dermatology at Mount Sinai West and Mount Sinai Beth Israel in New York, as well as the conference chair of the vitiligo portion of RAVE. At the conference, Dr. Silverberg presented “Topical Therapeutics for Vitiligo” and “Excellence in Vitiligo Clinical Practice.” Today, Dr. Silverberg shares the top takeaways from her sessions that clinicians can utilize in their practice. 

Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.

Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.

Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, caught up with us at the 2024 American Academy of Dermatology Meeting to decode new atopic dermatitis treatment data and how that translates to personalized options for patients.

Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition. 

Nanette Silverberg, MD, clinical professor of pediatrics and dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, recently led the annual Revolutionizing Vitiligo (ReV) Virtual Conference. Discover what you need to say to overcome insurance coverage hangups with ruxolitinib, the importance of early intervention, and gain an overview of topical guidelines for patients of all ages with vitiligo.

This episode recaps a discussion during a recent Masterclasses in Dermatology Atopic Dermatitis meeting. Course Director Emmy Graber, MD, MBA, moderated a faculty Q&A after sessions. She asked leading atopic dermatitis experts about bathing routine advice for patients and families. They took different ages, cultures, and more into consideration. Rebecca Smith, MD; Lawrence Eichenfield, MD; Zakiya Pressley Rice, MD; and Christopher Bunick, MD, PhD; weighed in.

In this episode, discover and learn how to address the unique challenges faced by college students diagnosed with atopic dermatitis—especially as they navigate new lifestyles and medication management. Dr. Ruchi Gupta will lead a session on this topic at the 2023 American College of Allergy, Asthma, & Immunology Meeting in Anaheim, California.

In this episode, we delve into pediatric atopic dermatitis with Dr. Colleen Cotton from National Children’s Hospital in Washington, DC. She recently presented a session at Maui Derm NP+PA Fall 2023 in Asheville, North Carolina, and addressed the important considerations in children, why it is better to use an ointment as opposed to a cream, drugs available by age, the importance of timing with live vaccines, and the pros and cons of pre-filled syringes versus injectable pens for young patients. 

Marty Makary, MD, MPH, FACS, is a professor at the Johns Hopkins University School of Medicine and Carey Business School, a member of the National Academy of Medicine, and a public health and public policy researcher. Makary is also a New York Times best-selling author of “Unaccountable: What Hospitals Won't Tell You and How Transparency Can Revolutionize Health Care,” and “The Price We Pay: What Broke American Health Care - And How to Fix it.” In this episode, Makary discusses the role of physician-led legislative advocacy in health care and dermatology, a topic he recently discussed in the keynote speech at the 2023 AADA Legislative Conference in Washington, DC, earlier this month.

In this episode, Peter Lio, MD, discusses pearls and takeaways from the atopic dermatitis panel he participated in at the 2023 Society of Pediatric Dermatology meeting.

In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses of the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.

In this episode, Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University School of Medicine and the associate director of Clinical Trials at CCD Research, discusses what dermatologists and patients with atopic dermatitis can expect as we transition from winter to spring, as well as new and emerging treatments and technologies for managing atopic dermatitis that she’s looking ahead to as the year progresses.

In this episode, Christopher Bunick, MD, PhD, associate professor of dermatology at the Yale School Medicine, and a Dermatology Times Editorial Advisory Board member, discusses a paper he recently co-authored, titled “JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies,” with Stefano Daniele, PhD candidate of the Medical Scientist Training Program at the Yale School of Medicine.  

In this episode, we sit down with Bernard Cohen, MD, a professor of dermatology at Johns Hopkins University Pediatric Dermatology and Cutaneous Laser Center. He details new, emerging data in the world of atopic dermatitis and some new information on treating newborns and what patients should do now to battle the dry winter weather.For additional news and insights, visit us at dermatologytimes.com

On this episode of "The Cutaneous Connection", Bernard Cohen, MD, professor of pediatrics and dermatology at Johns Hopkins University School of Medicine, talks about how physicians and patients should treat atopic dermatitis in the winter months, and some new data on treating newborns. For additional news and insights, visit us at dermatologytimes.com

Today we're joined by Jeffrey M. Cohen, MD, a board-certified medical dermatologist and the director of the Psoriasis Treatment Program at the Yale School of Medicine. In this episode, he talks treatment options for adolescents with atopic dermatitis, how the changing seasons can affect flare-ups, and what caregivers can do at home to help prevent extreme itching.  For additional news and insights, visit us at dermatologytimes.com

Peter Lio, MD, and clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis. For additional news and insights, visit us at dermatologytimes.com  

Raj Chovatiya, MD, PhD, and assistant professor of dermatology and director of the Center for Ecezma and Itch at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses the changing field of atopic dermatitis. He also talks about the importance of JAK inhibitors and the treatment options he looks forward to. For additional news and insights, visit us at dermatologytimes.com 

Lawrence Eichenfield, MD, of Rady Children's Hospital-San Diego, who discusses the importance of multidisciplinary in the dermatology specialty. He gives his own experience with working with other specialties along with tips on how to improve communication with other health professionals.  

In this episode, we sit down with Steven R. Feldman, MD, PhD, a dermatologist at Wake Forest Baptist Health, in North Carolina. Patient adherence to treatment, new treatments on the horizon for atopic dermatitis and more is discussed in this interview. 

In this interview we sit down with by Savina Aneja, MD, a board-certified dermatologist in practice at Advance Dermatology and Cosmetic Surgery in Orlando, Florida. We discuss about Melanoma Monday, which is May 2, 2022. This day is part of an awareness campaign by American Academy of Dermatology during National Melanoma Month. We talk about what are the most important part of a skin cancer screening, common misconceptions patients have regarding skin cancer, and much more in this interview. 

As we start Skin Cancer Awareness Month, John Jesitus, staff correspondent, interviews Zoe Diana Draelos, MD. She is an adjunct assistant professor of dermatology at Duke University School of Medicine in Durham, North Carolina, and chief medical editor of Dermatology Times®. They discuss sun protective clothing and its effectiveness as a protective barrier to the skin. Beyond that, there are certain sun protective additives in laundry that can help add sun protection to fabric by helping block the light from coming through the material. Draelos also talks trends to come in the future of sunscreen products and innovation in the field of sun protection.

Jonathan Silverberg, MD, the associate professor of dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses a poster presented at the Revolutionizing Atopic Dermatitis (RAD) December 2021 conference.

Zoe Diana Draelos, MD, FAAD, adjunct assistant professor of dermatology at Duke University School of Medicine in Durham, North Carolina, and chief medical editor for Dermatology Times® talks about her presentation "Optimizing Nutrition for Skin Health," at the 2022 American Academy of Dermatology Annual meeting. 

Today I’m joined by Zoe Diana Draelos, MD, a research and board-certified clinical dermatologist and chief medical editor of Dermatology Times® from Durham, North Carolina. She details the process of her new book, Cosmetic Dermatology: Procedures and Practice, which will be releasing in the United States in April of 2022.

Today I’m joined by James Beckman, MD. Dr. Beckman is a Biochemist, Board Certified Plastic Surgeon and Adjunct, Associate Clinical Professor-Dermatology Department at the University of Arkansas Medical School. He is also the Founder of Therapon Skin Health. Beckman is the creator of a topical application that stops the progression of a first or second degree burn. We discuss the science behind this burn reversal method, the complexities of working with burned skin, and what needs to be considered when working with a burned patient.    

Shay Moinuddin, MHA, CANS, RN, an aesthetic nurse specialist and clinical manager at the Few Institute in Chicago, Illinois, talks about stackable aesthetic treatments, how the aesthetic world has changed in the last 10 years, and how allied health care workers should be utilized in the practice. 

Today we are joined by Dr. Maryanne Makredes Senna, MD, assistant professor of dermatology at Harvard Medical school, and director of the Mass General Hospital Hair Loss Clinic and clinical research trials for hair loss disorders in Boston, Massachusetts. We discuss androgenetic alopecia or AGA, which is a common form of hair loss in both men and women. In men, this condition is also known as male-pattern baldness. We dive into current treatment challenges, new regeneration devices, and how to help patients with texture hair. For more information about the survey discussed in the podcast visit our article on the Dermatology Time's website called, "Androgenetic Alopecia Study Reveals Unmet Treatment Needs."

Managing editor of Dermatology Times, Mary Scoviak, is joined by Candrice Heath, MD, FAAP, FAAD a dermatologist and assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, to discuss relating to patients with textured hair.

This episode of The Cutaneous Connection podcast, sponsored by Incyte, explores the world of vitiligo. From symptoms to current treatment dissatisfaction and the latest research, Pearl Grimes, MD, FAAD, explains where we are now with this pigmentary disorder and where we are headed.

In this episode, we sit down with the OJM Group from Cincinnati, Ohio, to discuss qualified retirement plans and how many dermatology practices could be saving money. 

We dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource. 

This episode of The Cutaneous Connection podcast, Gary Linkov, MD, dives into the topic of hair loss. 

In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

This episode highlights findings from an investigative study exploring the molecular targeting of biologics for psoriasis, as well as discusses the interleukin(IL)-17 class of biologics, how this class compares to other classes such as IL-23 and TNFα, and how bimekizumab sets itself apart from other biologics in the pipeline for psoriasis.

This episode takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. Mark Lebwohl, MD, discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin diseases, and an outlook for the future of this drug class. 

In this episode, Assistant Editor Linda Stocum sits down with Jennifer Powers, MD, board certified dermatologist and associate professor of dermatology at the University of Iowa, to discuss her recent research exploring how diet and supplements affect patients with mild psoriasis.